Mirum Pharmaceuticals, Inc. (MIRM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
950 Tower Lane
Foster City, CA 94404
United States of America (the)
Phone
650 667 4085
Website
Sector
Healthcare
Industry
Biotechnology
Employees
334
First IPO Date
July 18, 2019
| Name | Title | Pay | Year Born |
| Christopher Peetz | Chief Executive Officer & Director | 1.83M | 1979 |
| Lara Longpre | Chief Development Officer | 678,200 | 1970 |
| Joanne J. Quan | Chief Medical Officer | 1M | 1964 |
| Eric H. Bjerkholt | Chief Financial Officer | 1M | 1960 |
| Peter Radovich | Chief Operating Officer & President | 1.16M | 1978 |
| Andrew McKibben | Senior Vice President, Strategic Finance & Investor Relations | 0 | N/A |
| Jean-Luc Girardet | Chief Technical Officer | 0 | N/A |
| Vinita Kumar | Senior Vice President of Quality | 0 | N/A |
| Meredith Kiernan | Senior Director of Global Corporate Communications | 0 | N/A |
| Erin Campany | Chief People Officer | 0 | 1968 |
| Douglas T. Sheehy | Chief Legal Officer & Secretary | 0 | 1967 |
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.